Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_4
1
11%
Ph phase_3
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Recruiting2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (25.0%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

active_not_recruiting111%
unknown222%
recruiting222%
not_yet_recruiting111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9